Progress in Pediatric Cardiology
Volume 27, Issue 1 , Pages 35-42 , December 2009

Pulmonary venous hypertension or pulmonary hypertension due to left heart disease

  • Ian Adatia

      Affiliations

    • Pediatric Pulmonary Hypertension Clinic, Division of Pediatric Cardiology, Stollery Children's Hospital, University of Alberta, Edmonton, Canada
    • Corresponding Author InformationCorresponding author. Room 3A1, 44 Walter C. Mackenzie Health Sciences Center, 8440 112 Street, Edmonton, AB, Canada T6G 3T7. Tel.: +1 780 407 3642.
    • ,
  • Tom Kulik

      Affiliations

    • Department of Cardiology, Children's Hospital Boston, 300 Longwood Ave, Boston, MA, USA
    • ,
  • Mary Mullen

      Affiliations

    • Department of Cardiology, Children's Hospital Boston, 300 Longwood Ave, Boston, MA, USA

References 

  1. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. Jun 16 2004;43(12 Suppl S):5S–12S
  2. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43–S54
  3. Adatia I. Pulmonary veno-occlusive disease. In:  Freedom RM,  Yoo SJ,  Mikailian H,  Williams WG editor. The natural and modified history of congenital heart disease. New York: Futura; 2004;p. 513
  4. Rich S, Rabinovitch M. Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation. Nov 18 2008;118(21):2190–2199
  5. Hoffman JI, Rudolph AM. The natural history of ventricular septal defects in infancy. Am J Cardiol. 1965;16:634–653
  6. Adatia I, Moore PM, Jonas RA, Colan SD, Lock JE, Keane JF. Clinical course and hemodynamic observations after supra-annular mitral valve replacement in infants and children. J Am Coll Cardiol. 1997;29:1089–1094
  7. Crepaz R, Pitscheider W, Oberhollenzer R, et al. Long-term follow-up in patients operated on for aortic coarctation. The echo-Doppler and MRI assessment of left ventricular function and the transisthmic gradient. G Ital Cardiol. Aug 1993;23(8):767–776
  8. Krogmann ON, Rammos S, Jakob M, Corin WJ, Hess OM, Bourgeois M. Left ventricular diastolic dysfunction late after coarctation repair in childhood: influence of left ventricular hypertrophy. J Am Coll Cardiol. May 1993;21(6):1454–1460
  9. Senzaki H, Kumakura R, Ishido H, Masutani S, Seki M, Yoshiba S. Left atrial systolic force in children: reference values for normal children and changes in cardiovascular disease with left ventricular volume overload or pressure overload. J Am Soc Echocardiogr. 2009;22(8):939–946
  10. Wood P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J. 1958;20:557–570
  11. Wood P. An appreciation of mitral stenosis part II investigations and results. Br Med J. may 15 1954;1:1113–1118
  12. Wood P, Besterman EM, Towers MK, McIlroy MB. The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis. Br Heart J. 1957;(19):279–286
  13. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol. 1995;25(7):1652–1664
  14. Loh E, Stamler J, Hare J, Loscalzo J, Colucci W. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90:2780–2785
  15. Atz AM, Adatia I, Jonas RA, Wessel DL. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Am J Cardiol. 1996;77:316–319
  16. Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg. 1996;62:1759–1764
  17. Bocchi EA, Bacal F, Auler Junior JO, Carmone MJ, Bellotti G, Pileggi F. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol. Jul 1 1994;74(1):70–72
  18. Atz AM, Adatia I, Lock JE, Wessel DL. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol. 1999;33(3):813–819
  19. Endo M, Yamaki S, Ohmi M, Tabayashi K. Pulmonary vascular changes induced by congenital obstruction of pulmonary venous return. Ann Thorac Surg. Jan 2000;69(1):193–197
  20. Collins-Nakai RL, Rosenthal A, Castaneda AR, Bernhard WF, Nadas AS. Congenital mitral stenosis. A review of 20years' experience. Circulation. Dec 1977;56(6):1039–1047
  21. Haworth SG, Reid L. Structural study of pulmonary circulation and of heart in total anomalous pulmonary venous return in early infancy. Br Heart J. 1977;39:80–92
  22. Yamaki S, Tsunemoto M, Shimada M, et al. Quantitative analysis of pulmonary vascular disease in total anomalous pulmonary venous connection in sixty infants. J Thorac Cardiovasc Surg. 1992;104:728–735
  23. Yamaguchi M, Hosokawa Y, Imai Y, et al. Early and midterm results of the arterial switch operation for transposition of the great arteries in Japan. J Thorac Cardiovasc Surg. 1990;100:261–269
  24. Du L, Sullivan CC, Chu D, et al. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med. Feb 6 2003;348(6):500–509
  25. Chaudry G, MacDonald C, Adatia I, Gundogan M, Manson D. CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children. Pediatr Radiol. Apr 2007;37(4):345–350
  26. Thadani U, Burrow C, Whitaker W, Heath D. Pulmonary veno-occlusive disease. QJM. 1975;44:133–159
  27. Louie EK, Rich S, Brundage BH. Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. J Am Coll Cardiol. Dec 1986;8(6):1298–1306
  28. Nootens M, Wolfkiel CJ, Chomka EV, Rich S. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol. Feb 15 1995;75(5):374–377
  29. Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48–54
  30. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol. Dec 1996;28(7):1775–1780
  31. Lister G, Hellenbrand WE, Kleinman CS, Talner NS. Physiologic effects of increasing hemoglobin concentration in left-to-right shunts in infants with ventricular septal defects. N Engl J Med. 1982;306:502–506
  32. Bloomfield DK. The natural history of ventricular septal defect in patients surviving infancy. Circulation. Jun 1964;29:914–955
  33. Auld PAM, Gibbons JE, McGregor M. Vasomotor tone in the pulmonary vascular bed in patients with left to right shunts. Br Heart J. 1963;25:257–261
  34. Beekman RH, Rochini AP, Rosenthal A. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect. Circulation. 1981;64:553–558
  35. Beekman RH, Rochini AP, Rosenthal A. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect. Circulation. 1982;65:523–528
  36. Dushane JW, Kirklin JW. Selection for surgery of patients with ventricular septal defect and pulmonary hypertension. Circulation. Jan 1960;21:13–20
  37. West JB, Dollery CT, Heard BE. Increased pulmonary vascular resistance in the dependent zone of the isolated dog lung caused by perivascular edema. Circ Res. Sep 1965;17:191–206
  38. Fishman AP. Respiratory gases in the regulation of the pulmonary circulation. Physiol Res. 1961;41(214):
  39. Vlahos AP, Lock JE, McElhinney DB, van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation. May 18 2004;109(19):2326–2330
  40. Glatz JA, Tabbutt S, Gaynor JW, et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg. 2007 Nov;84(5):1633–1638
  41. Maeda K, Yamaki S, Kado H, Asou T, Murakami A, Takamoto S. Hypoplasia of the small pulmonary arteries in hypoplastic left heart syndrome with restrictive atrial septal defect. Circulation. Sep 14 2004;110(11 Suppl 1):II139–II146
  42. Vida VL, Bacha EA, Larrazabal A, et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg. Aug 2007;84(2):581–585discussion 6
  43. Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol. 1999;34:554–560
  44. Freedom RM, Adatia I, Coles JG, Konstantinov I. Congenital stenosis of the individual pulmonary veins. In:  Freedom RM,  Yoo S-J,  Mikailian H,  Williams WG editor. The natural and modified history of congenital heart disease. New York: Futura; 2004;
  45. Wood P. An appreciation of mitral stenosis part 1 clinical features. Br Med J. May 8 1954;1:1051–1063
  46. Hawe A, Frye RL, Ellis FH. Late hemodynamic studies after mitral valve surgery. J Thorac Cardiovasc Surg. 1973;65:351–358
  47. Dalen JE, Matloff JM, Evans GL, et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement. NEMJ. 1967;277(8):387–394
  48. Kaul TK, Bain WH, Jones JV, et al. Mitral valve replacement in the presence of severe pulmonary hypertension. Thorax. 1976;31:332–336
  49. Braunwald E, Braunwald N, Ross J, Morrow AG. Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. NEMJ. 1965;273(10):509–514
  50. Zener JC, Hancock EW, Shumway NE, Harrison DC. Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol. Dec 1972;30(8):820–826
  51. Levine MJ, Weinstein JS, Diver DJ, et al. Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation. May 1989;79(5):1061–1067
  52. Fawzy ME, Hassan W, Stefadouros M, Moursi M, El Shaer F, Chaudhary MA. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis. Nov 2004;13(6):942–947discussion 7–8
  53. Fawzy ME, Stefadouros MA, Hegazy H, Shaer FE, Chaudhary MA, Fadley FA. Long term clinical and echocardiographic results of mitral balloon valvotomy in children and adolescents. Heart (Br Card Soc). Jun 2005;91(6):743–748
  54. Fawzy ME, Stefadouros M, El Amraoui S, et al. Long-term (up to 18years) clinical and echocardiographic results of mitral balloon valvuloplasty in children in comparison with adult population. J Interv Cardiol. Jun 2008;21(3):252–259
  55. McElhinney DB, Sherwood MC, Keane JF, del Nido PJ, Almond CS, Lock JE. Current management of severe congenital mitral stenosis: outcomes of transcatheter and surgical therapy in 108 infants and children. Circulation. Aug 2 2005;112(5):707–714
  56. Alexopoulos D, Lazzam C, Borrico S, Fiedler L, Ambrose JA. Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension. J Am Coll Cardiol. Aug 1989;14(2):319–322
  57. Shone J, Sellers R, Anderson R, Adams P, Lillehei C, Edwards J. The developmental complex of “parachute” mitral valve, supravalvular ring of left atrium, subaortic stenosis and coarctation of the aorta. Am J Cardiol. 1963;11:714–725
  58. Brauner RA, Laks H, Drinkwater DC, Scholl F, McCaffery S. Multiple left heart obstructions (Shone's anomaly) with mitral valve involvement: long-term surgical outcome. Ann Thorac Surg. Sep 1997;64(3):721–729
  59. Malhotra SP, Lacour-Gayet F, Campbell DN, et al. Outcomes of reparative and transplantation strategies for multilevel left heart obstructions with mitral stenosis. Ann Thorac Surg. Oct 2008;86(4):1305–1309discussion 10
  60. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. Jan 2001;37(1):183–188
  61. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation. 1987;76(suppl V):V 52–V 55
  62. Murali S, Kormos R, Uretsky B, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation. Am Heart J. 1993;126:896–904
  63. Kieler-Jensen N, Ricksten S-E, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant. 1994;13:366–375
  64. Klodell CT, Morey TE, Lobato EB, et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg. Jan 2007;83(1):68–71discussion
  65. Martin J, Siegenthaler MP, Friesewinkel O, et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation—a preliminary study. Eur J Cardiothorac Surg. Jun 2004;25(6):971–977
  66. Gandhi SK, Grady RM, Huddleston CB, Balzer DT, Canter CE. Beyond Berlin: heart transplantation in the “untransplantable”. J Thorac Cardiovasc Surg. Aug 2008;136(2):529–531
  67. Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. Jan 1998;113(1):237–240
  68. Humbert M, Maitre S, Capron F, Rain B, Musset D, Simonneau G. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am J Respir Crit Care Med. May 1998;157(5 Pt 1):1681–1685
  69. Lewis GD, Lachmann J, Camuso J, et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation. Jan 2 2007;115(1):59–66
  70. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol. Dec 21 2004;44(12):2339–2348
  71. Ramakrishnan S, Malik V, Karthikeyan G, et al. Acute hemodynamic effects of sildenafil in patients with idiopathic dilated cardiomyopathy. Indian Heart J. Nov–Dec 2008;60(6):599–601
  72. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. Nov 27 2007;50(22):2136–2144
  73. Packer M, McMurray J, Massie BM, et al. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. Feb 2005;11(1):12–20
  74. Califf RM, Adams KF, McKenna WJ, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. Jul 1997;134(1):44–54
  75. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. Mar 19 2002;105(11):1387–1393

PII: S1058-9813(09)00029-0

doi: 10.1016/j.ppedcard.2009.09.006

Progress in Pediatric Cardiology
Volume 27, Issue 1 , Pages 35-42 , December 2009

Article Tools

* Image Usage & Resolution